The surgeon was doing a burrhole for the insertion of electrodes when the perforator got jammed.It got stuck and the surgeon had a hard time taking it out.The perforator stopped.There's no harm to the patient but it wasn't a clean cut burrhole because some of the tissues got caught in the perforator burr.There was no issue in the first burrhole, not until the second burrhole procedure.It was reported surgical delay, unknown for how long.
|
The perforator was received for evaluation.Dhr - the batch record was reviewed for any anomalies or ncs related to the finished lot (j54g45), and there were no findings.Udi (b)(4), lot j54g45, manufactured: 19-sep-2019, and expires: 31-aug-2024, from the perforator product family.Failure analysis - visually inspected utilizing unaided eye.Anomalies include organic matter and rust.Complaint could not be verified.Unit was found to meet all applicable acceptance criteria.The root cause cannot be determined given the functional testing found the 261221 perforator met all applicable acceptance criteria.In addition, no issues relevant to the failure were noted from the dhr review, or trending, and proper finished goods testing was performed prior to release.Between 05nov2019 and 30jun2020, approximately 2,200 mdrs submitted electronically by integra lifesciences via trackwise, integra's complaint handling system, were not received by cdrh due to a computer system issue.Within this time period, an error with integra's middleware, which facilitates communications between trackwise and the fda system, caused the complaint records to close and indicate we had received an acknowledgement 3 from the fda when we had not.Integra interpreted the acknowledgement as a successful submission; however, subsequent investigation revealed the acknowledgement 3 received was from our middleware and not from the fda (these acknowledgements have been retained as part of the documentation of the mdr).The malfunction was related to the relocation of the trackwise application to a new data center during the transition of integra's corporate headquarters from plainsboro, nj to princeton, nj.Previously, integra had been successfully receiving acknowledgements 1, 2, and 3 from the fda, and our records reflect these acknowledgements, including the date and time stamps.Capa pr 229048 and nc 20-011 have been opened by integra to further investigate the nonconformance and develop a corrective action plan.The middleware error has been corrected, and integra has filed mdrs since the correction and verified that the appropriate acknowledgements have been received from the fda.Integra is resubmitting all impacted mdr reports for the time period 05nov2019 through 30jun2020.Integra lifesciences contacted (b)(4) office of product evaluation and quality on july 8-9, 2020 to report these issues regarding mdr reports.
|